HSBC Holdings
BMY.RT

HSBC Holdings’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

HSBC Holdings’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,453
Closed -$15K – 3308
2020
Q4 		$15K Sell
21,453
-32,741
-60% -$69.7K ﹤0.01% 3013
2020
Q3 		$119K Buy
54,194
+12,994
+32% +$37.1K ﹤0.01% 2597
2020
Q2 		$147K Sell
41,200
-26,579
-39% -$95.9K ﹤0.01% 2451
2020
Q1 		$259K Sell
67,779
-140,660
-67% -$463K ﹤0.01% 2142
2019
Q4 		$631K Buy
+208,439
New +$542K ﹤0.01% 2100

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

HSBC Holdings's BMY.RT Position: Q1 2021 in Review

HSBC Holdings sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 21,453 shares — an estimated $15K sold.

HSBC Holdings first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $631K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • HSBC Holdings reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • HSBC Holdings sold 21,453 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $15K.
  • HSBC Holdings first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • HSBC Holdings's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $631K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on HSBC Holdings's 13F filing for Q1 2021, filed 14 May 2021.